Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moy-Fincher-Chipps Facial Plastics and Dermatology is a premier medical group specializing in surgical, medical, and cosmetic dermatology. Based in Southern California, the practice is led by world-renowned experts in Mohs micrographic surgery and facial plastic reconstruction. The organization operates as a high-volume clinical research center, participating in numerous Phase 2 through Phase 4 clinical trials for global pharmaceutical and medical device companies. Their clinical expertise covers a broad spectrum of conditions, including skin cancer, inflammatory skin diseases, and aesthetic enhancements. In 2022, the practice joined the Golden State Dermatology network to expand its reach and resources. The firm is recognized for integrating cutting-edge laser technologies and innovative therapeutic modalities into standard patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moy-Fincher-Chipps Facial Plastics and Dermatology.